Chefaa, a technology platform championing patient-centric pharmacy benefits, has secured a strategic $5.25 million investment from a consortium of new and existing investors. The round was co-led by Newtown Partners (South Africa) and Global Brain (Japan), with participation from GMS Capital Partners LLC (US), Verod-Kepple Africa Ventures (Nigeria), and M3, Inc. (Japan).
This strategic infusion follows Chefaa's successful expansion into Saudi Arabia, where it now operates across 8 cities. The funding will fuel Chefaa's ambitions to:
"Our mission is to spearhead a secure digital transformation of healthcare through a patient-centric approach," stated Doaa Aref, CEO of Chefaa. "This investment validates our vision and empowers us to scale our impact across the region."
Investors echoed Chefaa's commitment to improving healthcare access and delivery.
Chefaa's dedication to patient-centricity and data-driven innovation has attracted a diverse mix of investors with a shared vision for the future of healthcare. This strategic boost paves the way for Chefaa to further revolutionize the pharmacy landscape and empower patients to take control of their health.
Play audio
No comments